Chris Johnson, former NFL running back known as CJ2K, publicly announced that he has been diagnosed with ALS
Former NFL running back Chris Johnson, one of the most explosive American football players of the late 2000s and early 2010s, has publicly announced that he was diagnosed in 2025 with amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig's disease. Johnson spoke about the diagnosis in a conversation for the American program Good Morning America, in an interview with Michael Strahan that aired on June 29, 2026. According to an ABC News report, Johnson discovered the disease at the age of 39, and today, at 40, he uses a speech-generating device to communicate. His statement attracted great attention because it concerns an athlete whose career was built on speed, physical endurance, and the ability to change the course of a game in a single play.
Johnson said in the interview that there is no history of ALS in his family and that his doctors believe it is a sporadic form of the disease. Such wording is important because ALS in most patients does not arise as a clearly inherited condition, but, according to medical sources, appears without a known family connection. Johnson also described how the first signs of the disease appeared as weakness in his right hand, which at first looked like a possible consequence of a long sports career. As he said in the conversation for Good Morning America, he initially noticed that his grip was not as it had been before and that his hand no longer had the strength he was used to.
The first symptoms began with weakening of the right hand
According to Johnson's description, the onset of the disease did not look dramatic, but appeared through small changes in everyday movements. Weakness of the right hand could at first resemble a nerve problem, an injury, or a lingering consequence of professional sport, especially because Johnson played ten seasons at the running back position, one of the most physically demanding in American football. His wife Brittany Johnson said in the same conversation that she herself initially thought it was something connected with football, for example a pinched nerve or a similar consequence of his career. The ALS diagnosis, according to her words, was not what the family expected.
The disease then changed Johnson's everyday life much faster than, according to his testimony, he expected. In the interview, he said that ALS can attack the body very quickly and gave a personal example: a little more than a year before the conversation, he could lift his seven-year-old daughter while she was blowing out candles on a birthday cake, and today he can no longer do that. Such details in his statement were not presented as a pathetic message, but as a way for the public to understand how quickly abilities can change with a progressive neurological disease. Johnson emphasized that ALS changes what his body can do, but not his identity, feelings, plans, or relationship with his family.
According to ABC News, shortly after the diagnosis Johnson had his own voice recorded so that the speech-generating device could reproduce it as faithfully as possible. This is important for people in whom ALS affects the muscles needed for speech because technology can help them retain a recognizable way of communicating, even though the physical ability to speak itself decreases or disappears. Johnson today speaks with the help of such a device, which makes his public appearance both a personal story of adapting to the disease and a public reminder of the importance of access to assistive devices. His message was that he should not be viewed only through the physical change the disease brings, but as a person who still thinks, dreams, loves his family, and wants to participate in life.
Sporadic ALS and a disease for which there is still no cure
ALS is a progressive neurodegenerative disease that affects motor neurons, the nerve cells responsible for transmitting signals from the brain and spinal cord to the muscles. According to the American National Institute of Neurological Disorders and Stroke, over time the disease leads to an increasing loss of voluntary muscle control, which can affect walking, using the hands, speaking, swallowing, and breathing. The same source states that almost all cases of ALS are considered sporadic, meaning that the disease appears seemingly at random, without clear risk factors and without a family history. A smaller portion of cases is described as familial or hereditary ALS, and in such patients genetic changes associated with the disease can be identified.
Medical experts emphasize that the course of ALS differs significantly from person to person. According to the National Institute of Neurological Disorders and Stroke, most people with ALS die from respiratory failure within three to five years after the onset of symptoms, but some patients live longer, including people who live with the disease for ten or more years. This statistic explains why Johnson in the interview particularly highlighted the need for earlier recognition of symptoms, the development of better therapies, and broader investment in research. There is currently no medicine that would cure ALS, but there are therapies and multidisciplinary care that can slow the progression of the disease in some patients, alleviate symptoms, and help preserve quality of life.
According to the American CDC's National ALS Registry, official data on prevalence and incidence in the United States of America are tracked through a special public health system that combines multiple sources, including health programs, veterans' care, and patient self-registration. The CDC states that the latest available prevalence data in the registry are for the calendar year 2018, while the latest published incidence data are for the period from 2014 to 2016. Such a time lag shows how difficult it is to precisely track rare diseases at the national level, especially when the diagnosis can be made gradually and after a series of neurological tests. For that reason, public statements by well-known people often have an additional role: they do not replace medical data, but they can increase the visibility of the disease and encourage earlier seeking of professional help.
From a record NFL season to life after professional sport
Johnson is best known to the wider sports public for his time with the Tennessee Titans, who selected him in the first round of the 2008 NFL Draft. According to official NFL statistics, he played 130 games in the league and recorded 9,651 rushing yards and 55 rushing touchdowns. In addition, he had 307 receptions for 2,255 yards and another nine receiving touchdowns, confirming that he was a threat both in the running game and in the passing game. After six seasons in Tennessee, he played for the New York Jets and Arizona Cardinals, and he ended his career in 2017.
His 2009 season remains one of the best-known individual seasons in NFL history. According to official NFL statistics, Johnson rushed for 2,006 yards for the Tennessee Titans that year, with an average of 5.6 yards per attempt and 14 rushing touchdowns. He also added 50 receptions for 503 yards and two receiving touchdowns, bringing his total to 2,509 yards from scrimmage. Pro Football Reference's ranking of single seasons by total yards from scrimmage still lists him in first place with that 2009 number, ahead of other major NFL names. It was precisely crossing the threshold of 2,000 rushing yards that cemented the nickname CJ2K, which became a lasting part of his sporting identity.
But Johnson's current message is not aimed only at remembering his sports career. In the conversation for Good Morning America, he said that after the diagnosis he was in shock, but that at one point he realized he had a choice between giving up and fighting. His statement that he chose to fight became the central part of the story, but not in the sense of a simplified sports metaphor. With ALS, the disease cannot be defeated by willpower, but Johnson wanted to emphasize the decision to continue seeking care, participating in research, speaking publicly, and remaining present in his family's life.
Family, care, and the role of doctors in Johnson's fight
In his public appearance, Johnson particularly highlighted his wife Brittany and their four children. He said that the children motivate him every day because he wants more time with them, more shared memories, and the opportunity to continue being their father. Brittany Johnson described caring for her husband as a difficult and demanding job, but emphasized that she has no doubts about her role in that process. Her words point to a part of ALS that the public often sees only through personal stories: the disease changes not only the person who has been diagnosed, but also the everyday life of the entire family, including the emotional burden, organization of care, financial decisions, and constant adaptation of the home and routines.
According to ABC News, Johnson's family contacted Dr. Merit Cudkowicz after seeing an earlier television conversation about ALS. Cudkowicz is a neurologist connected with Harvard Medical School and the Mass General Brigham Neuroscience Institute, and according to her Massachusetts General Hospital profile, her work is focused on clinical research and the development of therapies for ALS. In the conversation for Good Morning America, she said that Johnson was receiving standard care, including several medications that can slow the disease, and that he also participated in a clinical trial of a therapy aimed at reducing inflammation. She emphasized that she believes this could have helped in his fight, although from the available information it is not possible to conclude how great the effect of any individual intervention was in his case.
Johnson's case also shows why clinical trials are important, but also why they must be discussed cautiously. Experimental therapies do not mean a certain outcome and cannot be presented as confirmed medicines until their safety and effectiveness have been proven in controlled studies. Still, according to information from the Sean M. Healey and AMG Center for ALS at Massachusetts General Hospital, the goal of that center is to accelerate the development of therapies for hundreds of thousands of people in the world who live with ALS. In Johnson's case, a possibility of supporting ALS research in his honor was also publicly established at that center, which further connects his personal statement with efforts to expand scientific research and clinical care.
Why the public testimony of well-known people matters for ALS
ALS is a relatively rare disease, but its impact on patients and families is exceptionally great. Because it can begin with mild symptoms, such as weakness in the hand, changes in gait, muscle twitching, slurred speech, or difficulty swallowing, the diagnosis is often not immediate. According to medical sources, confirmation of the disease requires a neurological examination and tests that rule out other conditions with similar symptoms. Johnson's story therefore carries a public health message: not every hand weakness means ALS, but persistent or progressive changes in strength, speech, swallowing, or movement require a medical evaluation.
His statement also recalls the difference between athletic endurance and the medical reality of neurodegenerative diseases. During his career, Johnson was a symbol of speed and explosiveness, and in the 2009 season he achieved a performance that is still cited among the most important individual accomplishments in NFL history. That is precisely why his diagnosis resonates so strongly: a disease that affects motor neurons can change a person's life regardless of previous physical fitness, sporting past, or public status. Johnson himself emphasized that he wants people to understand how ALS can affect a person who never expected it.
For the sports world, Johnson's announcement also comes as a continuation of a broader conversation about the health of former professional athletes. In his case, according to the available information, doctors described the diagnosis as sporadic ALS, without a confirmed family connection, and Johnson himself did not claim that the disease was a consequence of his football career. Such a distinction is important because public discussion must separate personal experience from medically confirmed causal links. At the same time, his example can encourage greater interest in neurological health, rehabilitation, long-term care, and research that goes beyond sport.
Johnson's final message in the interview was directed toward the dignity of patients. He said that ALS did not change who he is, but what his body can do. That sentence summarizes the main public value of his statement: it is a call for people with ALS not to be viewed only through disability, but through their relationships, thoughts, wishes, fears, and plans. As research continues and families adapt every day to the demands of the disease, Johnson decided to use his recognizability so that ALS would receive more space in the public eye and so that there would be stronger discussion of the need for earlier recognition, better therapies, and greater support for those living with the disease.
Sources:
- ABC7 New York / ABC News – report on Chris Johnson's interview for Good Morning America, ALS diagnosis, family statements, and medical context (link)
- NFL.com – official statistics of Chris Johnson's career and performance by season (link)
- Pro Football Reference – ranking of the greatest single seasons by yards from scrimmage in NFL history (link)
- National Institute of Neurological Disorders and Stroke – medical overview of ALS, symptoms, forms of the disease, and prognosis (link)
- CDC National ALS Registry – public health data on estimates of ALS prevalence and incidence in the United States of America (link)
- Massachusetts General Hospital, Sean M. Healey and AMG Center for ALS – information about the research center and the development of therapies for ALS (link)
- Massachusetts General Hospital – profile of Dr. Merit Cudkowicz and description of her work on ALS and neurological clinical research (link)
- Massachusetts General Hospital Giving – page for supporting ALS research in honor of Chris Johnson (link)